TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” ...
In its first-quarter 2026 investor letter, TimesSquare Capital U.S. Mid Cap Growth Strategy highlighted Ionis Pharmaceuticals ...
Things To Do in Dubai on MSN
The future of biotech? BridgeBio, Ionis and BioMarin are worth watching
While investors have long treated the pharmaceuticals’ industry with caution, those that avoid the sector are missing out on clear opportunities. While navigating the fast-developing industry is not ...
Amgen Inc. (NASDAQ:AMGN) ranks among the top NASDAQ stocks for retirement. On June 16, Mizuho increased its price target for ...
The FDA has approved Tryngolza (olezarsen) to reduce triglycerides and acute pancreatitis risk in adults with severe hypertriglyceridemia (TG ≥500mg/dL).
President Donald Trump has promised to make U.S. prescription drug prices the cheapest in the world, but a closely watched ...
Diranersen presentation will feature Phase 2 CELIA data in early Alzheimer's disease, including clinical, biomarker and safety results for Biogen's investigational tau-targeting ASO, following topline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results